Molecular Oncology (Jan 2019)

Intricate crosstalk between MYC and non‐coding RNAs regulates hallmarks of cancer

  • Lotteke J. Y. M. Swier,
  • Agnieszka Dzikiewicz‐Krawczyk,
  • Melanie Winkle,
  • Anke van denBerg,
  • Joost Kluiver

DOI
https://doi.org/10.1002/1878-0261.12409
Journal volume & issue
Vol. 13, no. 1
pp. 26 – 45

Abstract

Read online

Myelocytomatosis viral oncogene homolog (MYC) plays an important role in the regulation of many cellular processes, and its expression is tightly regulated at the level of transcription, translation, protein stability, and activity. Despite this tight regulation, MYC is overexpressed in many cancers and contributes to multiple hallmarks of cancer. In recent years, it has become clear that noncoding RNAs add a crucial additional layer to the regulation of MYC and its downstream effects. So far, twenty‐five microRNAs and eighteen long noncoding RNAs that regulate MYC have been identified. Thirty‐three miRNAs and nineteen lncRNAs are downstream effectors of MYC that contribute to the broad oncogenic role of MYC, including its effects on diverse hallmarks of cancer. In this review, we give an overview of this extensive, multilayered noncoding RNA network that exists around MYC. Current data clearly show explicit roles of crosstalk between MYC and ncRNAs to allow tumorigenesis.

Keywords